91黑料 experts frequently author or contribute to industry trade press.
Filter media
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category. Note - not all categories will display results if selecting a particular year.
-
Experts from the Commercial Solutions team discuss .
-
summarises 91黑料’s quarterly and 2021 year-end financial results.
-
shares how the medical and biotech sectors have dominated the mergers & acquisitions (M&A) landscape and mentions 91黑料’s acquisition of PRA Health Sciences. (registration required)
-
provides an overview of the mergers and acquisition activity that took place in Ireland across 2021. This includes 91黑料’s $12bn acquisition of PRA Health Sciences as one of the “big deals of 2021”. (Registration required)
-
: This piece focusses on people’s stories and their past motivations in life that have led them to where they are today.
: This piece considers the struggles people have faced working within STEM whilst building their careers and how they have overcome these hurdles.
: This piece focusses on celebrating the achievements of Black women who work within STEM, to highlight International Day of Women and Girls in Science 2022.
: This piece highlights the advice our experts have received during their careers and the resources they have found the most helpful.
: This piece examines the achievements our experts have attained in their careers whilst working within the STEM industry.
: The final piece highlights our experts’ advice for those who are in the early stages of their careers.
-
Brian Huber, Vice President, Drug Development Services, considers .
-
considers how partnering with a CRO can help emerging biotechs to secure funding.
-
In , Steve Cutler comments on 91黑料’s success in decentralised trials and therapeutic technologies such as mRNA and checkpoint inhibitors.
-
discusses 91黑料’s forecast revenues for 2022 and includes a statement from Steve Cutler on 91黑料’s successes from 2021.
-
Cindy Spittle shares insights on the growth of molecular diagnostic testing in clinical trials.
